Cargando…

Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures

OBJECTIVE: This research aims to investigate and analyze the impact of alendronate sodium (ALN) plus elcatonin (EC) in treating postoperative bone pain (BP) in patients with osteoporotic fractures (OPFs). METHODS: One hundred and thirty-eight cases of OPFs admitted between July 2018 and July 2021 we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Baohui, Sun, Yindi, Shi, Da, Han, Xiuwei, Liu, Na, Wang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473873/ https://www.ncbi.nlm.nih.gov/pubmed/36119926 http://dx.doi.org/10.1155/2022/1213278

Ejemplares similares

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Elcatonin attenuates disuse osteoporosis after fracture fixation of tubular bone in rats
por: Ji, Zhe, et al.
Publicado: (2015)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals
por: de OLIVEIRA, Danila, et al.
Publicado: (2017)

Improvement of Quality of Life (QOL) in Osteoporotic Patients by Elcatonin Treatment: A Trial Taking the Participants’ Preference into Account
por: Yoh, K., et al.
Publicado: (2012)

Effects of hip replacement combined with alendronate sodium on postoperative healing of osteoporotic femoral neck fracture and levels of CTX-1 and BALP in patients
por: Ouyang, Xiao, et al.
Publicado: (2019)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
por: Iwamoto, Jun, et al.
Publicado: (2011)

Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions
por: van Houdt, Claire I. A., et al.
Publicado: (2018)

The Gradual Release of Alendronate for the Treatment of Critical Bone Defects in Osteoporotic and Control Rats
por: Hedvičáková, Věra, et al.
Publicado: (2023)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Anti-Nociceptive Effects of Elcatonin Injection for Postmenopausal Women with Back Pain: A Randomized Controlled Trial
por: Ikegami, Shota, et al.
Publicado: (2010)

Modifying collagen with alendronate sodium for bone regeneration applications
por: He, Yingcong, et al.
Publicado: (2018)

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation
por: Pedersen, Alma B., et al.
Publicado: (2019)

Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
por: Kim, Kwang Joon, et al.
Publicado: (2014)

Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
por: Okamoto, Hiroaki, et al.
Publicado: (2020)

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients
por: Hsu, Tsuen-Wei, et al.
Publicado: (2019)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Analyses of the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture and the risk factors of fracture
por: Li, Pengbin, et al.
Publicado: (2018)

Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors
por: Asaoka, Daisuke, et al.
Publicado: (2016)

Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer
por: Rouach, Vanessa, et al.
Publicado: (2018)

Bone healing study of alendronate combined with enoxaparin sodium bone cement in rabbits with bone defects
por: Xiao, Zhihang, et al.
Publicado: (2022)

The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects
por: Chiu, Wei-Yih, et al.
Publicado: (2018)

Effects of Alendronate Sodium Content on the Interface Strengths of Composite Acrylic Bone Cement
por: Song, De-Ye, et al.
Publicado: (2015)

Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand
por: Songpatanasilp, Thawee, et al.
Publicado: (2018)

Effect of Age and Sodium Alendronate on Femoral Fracture Repair: Biochemical and Biomechanical Study in Rats
por: Bonetto, Luana Mordask, et al.
Publicado: (2021)

In vivo study of bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate as injectable bone substitute composite in osteoporotic animal model
por: Budiatin, Aniek Setiya, et al.
Publicado: (2022)

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
por: Mori, Satoshi, et al.
Publicado: (2022)

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
por: Bitto, A, et al.
Publicado: (2008)

The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy
por: Sewerynek, Ewa, et al.
Publicado: (2013)

Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study
por: Alishiri, Gholamhossein, et al.
Publicado: (2020)

Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2020)

Formulation and In Vitro Evaluation of Alendronate Sodium/PLGA Microspheres for Applications in Bone Related Disorders
por: DECA, A.G., et al.
Publicado: (2015)

Relationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic Fracture Patients
por: Kwak, Mi Kyung, et al.
Publicado: (2015)

Risk factors of postoperative bone cement leakage on osteoporotic vertebral compression fracture: a retrospective study
por: Zhang, Kui, et al.
Publicado: (2021)

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
por: Bone, H. G., et al.
Publicado: (2017)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
por: Mori, Takahiro, et al.
Publicado: (2019)

The Comparison of Bone Scan and MRI in Osteoporotic Compression Fractures
por: Kim, Jung-Hoon, et al.
Publicado: (2010)

Analysis of Pre- and Postoperative Pain Variation in Osteoporotic Vertebral Compression Fracture Patients Undergoing Kyphoplasty
por: Mei, Xin, et al.
Publicado: (2017)

The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
por: Viggers, Rikke, et al.
Publicado: (2022)

Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
por: Cho, Yoon Je, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_02hst677t057sncddbgrvhmslc